Kaposi sarcoma (KS), one of the 3 AIDS-defining cancers, is a tumor that is associated with immunosuppression, and its presence in people with human immunodeficiency virus (HIV) warrants a diagnosis of HIV/AIDS.
1 Kaposi sarcoma manifests as cutaneous purplish, reddish-blue, or dark brown or black macules, plaques, and nodules on the lower extremities,
2-6 which has also been found to spread to the gastrointestinal tract, oral cavity, lungs, and lymph nodes.
7-9 The different forms of identified KS are as follows: (1) classic KS, found commonly in Jewish, Mediterranean, and Middle Eastern HIV-negative elderly men
5,10; (2) African KS, also known as endemic KS; (3) AIDS-associated KS, also known as epidemic KS, which is common in individuals with advanced immunodeficiency
2; and (4) iatrogenic KS.
8 Before the advent of AIDS, KS was found in elderly men.
11 However, after the emergence of HIV/AIDS, it has become more common in younger patients with AIDS and weaker immune systems.
12